These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 18495783)
1. Opposing regulation of neutrophil apoptosis through the formyl peptide receptor-like 1/lipoxin A4 receptor: implications for resolution of inflammation. El Kebir D; József L; Filep JG J Leukoc Biol; 2008 Sep; 84(3):600-6. PubMed ID: 18495783 [TBL] [Abstract][Full Text] [Related]
2. Aspirin-triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils: a novel mechanism for resolution of inflammation. El Kebir D; József L; Khreiss T; Pan W; Petasis NA; Serhan CN; Filep JG J Immunol; 2007 Jul; 179(1):616-22. PubMed ID: 17579083 [TBL] [Abstract][Full Text] [Related]
3. Neutrophil apoptosis: a target for enhancing the resolution of inflammation. Filep JG; El Kebir D J Cell Biochem; 2009 Dec; 108(5):1039-46. PubMed ID: 19760640 [TBL] [Abstract][Full Text] [Related]
4. Serum amyloid A inhibits apoptosis of human neutrophils via a P2X7-sensitive pathway independent of formyl peptide receptor-like 1. Christenson K; Björkman L; Tängemo C; Bylund J J Leukoc Biol; 2008 Jan; 83(1):139-48. PubMed ID: 17962368 [TBL] [Abstract][Full Text] [Related]
5. Lipoxin A(4) metabolites/analogues from two commercial sources have no effects on TNF-alpha-mediated priming or activation through the neutrophil formyl peptide receptors. Forsman H; Dahlgren C Scand J Immunol; 2009 Oct; 70(4):396-402. PubMed ID: 19751275 [TBL] [Abstract][Full Text] [Related]
6. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Chiang N; Serhan CN; Dahlén SE; Drazen JM; Hay DW; Rovati GE; Shimizu T; Yokomizo T; Brink C Pharmacol Rev; 2006 Sep; 58(3):463-87. PubMed ID: 16968948 [TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid upregulation of the annexin-A1 receptor in leukocytes. Sawmynaden P; Perretti M Biochem Biophys Res Commun; 2006 Nov; 349(4):1351-5. PubMed ID: 16973129 [TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. Chiang N; Arita M; Serhan CN Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):163-77. PubMed ID: 16125378 [TBL] [Abstract][Full Text] [Related]
11. Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor. Dalli J; Consalvo AP; Ray V; Di Filippo C; D'Amico M; Mehta N; Perretti M J Immunol; 2013 Jun; 190(12):6478-87. PubMed ID: 23686496 [TBL] [Abstract][Full Text] [Related]
12. Lipoxins and aspirin-triggered lipoxins in neutrophil adhesion and signal transduction. Filep JG; Khreiss T; József L Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):257-62. PubMed ID: 15979865 [TBL] [Abstract][Full Text] [Related]
13. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells. Fierro IM; Colgan SP; Bernasconi G; Petasis NA; Clish CB; Arita M; Serhan CN J Immunol; 2003 Mar; 170(5):2688-94. PubMed ID: 12594298 [TBL] [Abstract][Full Text] [Related]
14. Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils. Bae YS; Park JC; He R; Ye RD; Kwak JY; Suh PG; Ho Ryu S Mol Pharmacol; 2003 Sep; 64(3):721-30. PubMed ID: 12920210 [TBL] [Abstract][Full Text] [Related]
15. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1. Stenfeldt AL; Karlsson J; Wennerås C; Bylund J; Fu H; Dahlgren C Biochem Pharmacol; 2007 Oct; 74(7):1050-6. PubMed ID: 17692291 [TBL] [Abstract][Full Text] [Related]
16. Myeloperoxidase delays neutrophil apoptosis through CD11b/CD18 integrins and prolongs inflammation. El Kebir D; József L; Pan W; Filep JG Circ Res; 2008 Aug; 103(4):352-9. PubMed ID: 18617697 [TBL] [Abstract][Full Text] [Related]
17. Serum amyloid A opposes lipoxin A₄ to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease. Bozinovski S; Uddin M; Vlahos R; Thompson M; McQualter JL; Merritt AS; Wark PA; Hutchinson A; Irving LB; Levy BD; Anderson GP Proc Natl Acad Sci U S A; 2012 Jan; 109(3):935-40. PubMed ID: 22215599 [TBL] [Abstract][Full Text] [Related]
18. 15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury. El Kebir D; József L; Pan W; Wang L; Petasis NA; Serhan CN; Filep JG Am J Respir Crit Care Med; 2009 Aug; 180(4):311-9. PubMed ID: 19483113 [TBL] [Abstract][Full Text] [Related]
19. Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. Chiang N; Fierro IM; Gronert K; Serhan CN J Exp Med; 2000 Apr; 191(7):1197-208. PubMed ID: 10748237 [TBL] [Abstract][Full Text] [Related]
20. PTX3, a key component of innate immunity, is induced by SAA via FPRL1-mediated signaling in HAECs. Dong Z; An F; Wu T; Zhang C; Zhang M; Zhang Y; An G; An F J Cell Biochem; 2011 Aug; 112(8):2097-105. PubMed ID: 21465531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]